The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma

Background: Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and is associated with a median overall survival (mOS) of 16–21 months. Our previous work found a negative association between advanced aging and the survival benefit after treatment with immunotherapy in an experime...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Ladomersky, Erik, Scholtens, Denise M., Kocherginsky, Masha, Hibler, Elizabeth A., Bartom, Elizabeth T., Otto-Meyer, Sebastian, Zhai, Lijie, Lauing, Kristen L., Choi, Jaehyuk, Sosman, Jeffrey A., Wu, Jennifer D., Zhang, Bin, Lukas, Rimas V., Wainwright, Derek A.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6446059/
https://ncbi.nlm.nih.gov/pubmed/30971917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados